Kilter Cure India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 619.87%
(FY 2022)
- Profit 69.75%
(FY 2022)
- Ebitda 70.26%
(FY 2022)
- Net Worth -9.47%
(FY 2022)
- Total Assets 76.60%
(FY 2022)
About Kilter Cure India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajashekar Dadireddy and Mukthapuram Sujathamma serve as directors at the Company.
- CIN/LLPIN
U85110KA2015PTC084656
- Company No.
084656
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kilter Cure India Private Limited offer?
Kilter Cure India Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Kilter Cure India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajashekar Dadireddy  | Director | 11-Dec-2015 | Current |
| Mukthapuram Sujathamma | Director | 21-Dec-2022 | Current |
Financial Performance of Kilter Cure India.
Kilter Cure India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 619.87% increase. The company also saw a substantial improvement in profitability, with a 69.75% increase in profit. The company's net worth dipped by a decrease of 9.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kilter Cure India?
In 2022, Kilter Cure India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kilter Cure India?
Unlock and access historical data on people associated with Kilter Cure India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kilter Cure India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kilter Cure India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
